Related Experiment Video
Updated: Oct 5, 2026

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 16, 2013
Inhibition of estrone sulfatase and 17 beta-hydroxysteroid dehydrogenase by antiestrogens
1Department of Medicine, Milton S. Hershey Medical Center, Penn State University, Hershey 17033.
Abstract:
Circulating estrone sulfate levels are 10-fold higher than the free estrone and estradiol levels in postmenopausal women and could form a reservoir from which the free estrogens could be synthesized in situ in breast cancer tissues. The enzymes catalyzing conversion of estrone sulfate to free estrone and estradiol are estrone sulfatase and 17 beta-hydroxysteroid dehydrogenase, respectively. Selective blockade of these two enzymes may provide a means of reducing tumor estrogen levels and promoting tumor regression. The present study characterized the kinetics of several potential inhibitors of estrone sulfatase and 17 beta-hydroxysteroid dehydrogenase in vitro in rat breast tumors and compared these effects to those in human tissues. The antiestrogen ICI 164384 as well as tamoxifen and its metabolites inhibit estrone sulfatase via noncompetitive mechanisms at Kis ranging from 11-1130 microM in rat breast tumors. The steroid sulfates (pregnenolone sulfate and dehydroepiandrosterone sulfate) on the other hand, act as competitive inhibitors with Kis ranging from 4 to 6 microM. ICI 164384 and the tamoxifen metabolite 4-hydroxytamoxifen also blocked 17 beta-hydroxysteroid dehydrogenase at concentrations of 470 and 275 microM, respectively. In human breast tumors, 4-hydroxytamoxifen and desmethyltamoxifen blocked estrone sulfatase and 17 beta-hydroxysteroid dehydrogenase but at higher concentrations than in the rat (i.e. IC50s of 1000-2000 microM). The inhibition caused by the antiestrogens requires concentrations at least 100-fold higher than those necessary for antiestrogenic effects. Although blockade of enzyme action is significant in vitro, and could also be in vivo, the effects of antiestrogens on enzyme inhibition are likely to be outweighed by their ability to block estrogen receptor-mediated effects in patients.
Related Concept Videos
Drug Metabolism: Phase II Reactions
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Antihypertensive Drugs: Thiazide-Class Diuretics
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

